Similar articles

• Pharmacokinetics and biopharmaceutics of some adrenergic beta-receptor antagonists with special emphasis on alprenolol and metoprolol.

  Regårdh CG. Regårdh CG. Acta Pharmacol Toxicol (Copenh). 1975;37(1):1-39. doi: 10.1111/j.1600-0773.1975.tb03091.x. Acta Pharmacol Toxicol (Copenh). 1975. PMID: 237402 No abstract available.
• [Clinical pharmacology of trimepranol (pharmacokinetic informations and effects on heart rate in healthy individuals)].

  Mayer O, Petrlík M, Vitous J, Cepelák V. Mayer O, et al. Vnitr Lek. 1976 Nov;22(11):1102-9. Vnitr Lek. 1976. PMID: 12612 Czech. No abstract available.
• Proceedings: Preliminary observations on the human pharmacology of I.C.I. 66082 in normal volunteers.

  Graham BR, Littlejohns DW, Prichard BN, Scales B, Southorn P. Graham BR, et al. Br J Pharmacol. 1973 Sep;49(1):154P-155P. Br J Pharmacol. 1973. PMID: 4150762 Free PMC article. No abstract available.
• [Biotransformation and pharmacokinetics of beta-receptor blockaders].

  Pfeifer S, Zimmer C. Pfeifer S, et al. Pharmazie. 1975 Oct;30(10):625-33. Pharmazie. 1975. PMID: 685 Review. German. No abstract available.
• A survey of the pharmacological properties of metoprolol in animals and man.

  Ablad B, Borg KO, Carlsson E, EK L, Johnson G, Malmfors T, Regårdh CG. Ablad B, et al. Acta Pharmacol Toxicol (Copenh). 1975;36(Suppl 5):7-23. doi: 10.1111/j.1600-0773.1975.tb03318.x. Acta Pharmacol Toxicol (Copenh). 1975. PMID: 1094804 Review. No abstract available.